We describe how the function of key enzymes involved in ceramide metabolism—acid sphingomyelinase (which converts sphingomyelin to ceramide) and acid ceramidase (which converts ceramide to sphingosine)—is altered in CF. This evidence concerns the gene SMPD1 and cystic fibrosis.